Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases of Central Nervous System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT07555561
What this trial is testing

Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Central Nervous System LymphomaRelapsed/Refractory Primary Central Nervous System LymphomaRelapsed/Refractory Secondary Central Nervous System Lymphoma
Beijing Boren Hospital 30
Not applicableNot Yet RecruitingNCT06803186
What this trial is testing

High Power Laser on Suboccipital Myoelectrical Activities and Quality of Life in Patients With Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
Cairo University 40
Not applicableUnknownNCT03226483
What this trial is testing

Intraoperative Radiotherapy After the Resection of Brain Metastases

Who this might be right for
Brain Metastases
Universitätsmedizin Mannheim 50
Large-scale testing (Phase 3)WithdrawnNCT05312645
What this trial is testing

Diclofenac Gel in the Treatment of Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
Loma Linda University
Not applicableStudy completedNCT02026596
What this trial is testing

SpareBrain - Mechanisms and Prevention of Secondary Brain Injury in Subarachnoid Haemorrhage

Who this might be right for
Aneurysmal Subarachnoid Hemorrhage
Tampere University Hospital 61
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Not applicableLooking for participantsNCT07838545
What this trial is testing

Comparative Effects of Post Isometric Relaxation and Reciprocal Inhibition in Individuals With Cervicogenic Headache.

Who this might be right for
Post Traumatic HeadacheCervicogenic Headache
Foundation University Islamabad 46
Large-scale testing (Phase 3)Ended earlyNCT00699283
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 62
Early research (Phase 1)Ended earlyNCT00477503
What this trial is testing

Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

Who this might be right for
Central Nervous System TumorsBrain Tumors
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT01865942
What this trial is testing

Surgical Spinal Decompression of Metastatic Spinal Cord Compression, Minimal Access Versus Open Surgery

Who this might be right for
Spinal Metastases
Rigshospitalet, Denmark 50
Not applicableStudy completedNCT06395909
What this trial is testing

Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis+1 more
Novartis 113
Large-scale testing (Phase 3)Study completedNCT05807893
What this trial is testing

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more
Sun Yat-sen University 40
Large-scale testing (Phase 3)Ended earlyNCT00468611
What this trial is testing

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary Progressive
BioMS Technology Corp. 510
Not applicableUnknownNCT02618265
What this trial is testing

Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research

Who this might be right for
Stroke
Peking University Third Hospital 400
Not applicableLooking for participantsNCT06231186
What this trial is testing

A Feasibility Study of iHD-SRT for BM

Who this might be right for
Brain Metastases, AdultStereotactic Radiotherapy
Ruijin Hospital 35
Early research (Phase 1)Ended earlyNCT00089245
What this trial is testing

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
Y-mAbs Therapeutics 177
Not applicableStudy completedNCT04890028
What this trial is testing

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

Who this might be right for
Brain MetastasesMRI
Institut Cancerologie de l'Ouest 32
Early research (Phase 1)Ended earlyNCT03711422
What this trial is testing

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal DiseaseCentral Nervous System Metastases
National Cancer Centre, Singapore 2
Not applicableEnded earlyNCT03730896
What this trial is testing

Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches

Who this might be right for
Cervicogenic Headache
Florida Gulf Coast University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04992013
What this trial is testing

Niraparib in Tumors Metastatic to the CNS

Who this might be right for
Metastatic CancerCentral Nervous System Cancer
Massachusetts General Hospital 20
Next Page